These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3462309)

  • 21. The effect of pentoxifylline on the flow properties of human blood.
    Ehrly AM
    Curr Med Res Opin; 1978; 5(8):608-13. PubMed ID: 710175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease.
    Angelkort B; Maurin N; Boateng K
    Curr Med Res Opin; 1979; 6(4):255-8. PubMed ID: 527350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
    Reilly DT; Quinton DN; Barrie WW
    N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Alopecia areata. Hemorheological study and treatment with pentoxifylline].
    Trevisan G; Cisilin MP
    G Ital Dermatol Venereol; 1988 May; 123(5):211-4. PubMed ID: 3209239
    [No Abstract]   [Full Text] [Related]  

  • 25. Pentoxifylline and intermittent claudication.
    Spittel JA
    Ann Intern Med; 1985 Jan; 102(1):126-7. PubMed ID: 3966730
    [No Abstract]   [Full Text] [Related]  

  • 26. Some haemorheological factors in patients with arteriosclerosis obliterans after treatment of trental.
    Chyzy R; Lukjan H; Rość D; Bielawiec M; Sawicka J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):549-54. PubMed ID: 2446996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of pentoxifylline on the deformability of erythrocytes in erythrocyte concentrates in additive solution].
    Pindur G; Sander A; Seyfert UT; Jung F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Mar; 36 Suppl 1():S59-61. PubMed ID: 11322114
    [No Abstract]   [Full Text] [Related]  

  • 28. Alteration in erythrocyte membrane structure in Duchenne muscular dystrophy.
    Wakayama Y; Hodson A; Pleasure D; Bonilla E; Schotland DL
    Ann Neurol; 1978 Sep; 4(3):253-6. PubMed ID: 718137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of pentoxifylline on erythrocyte deformability and on phosphatide fatty acid distribution in the erythrocyte membrane.
    Schubotz R; Mühlfellner O
    Curr Med Res Opin; 1977; 4(9):609-17. PubMed ID: 590022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of pentoxifylline with human erythrocytes. II. Effects of pentoxifylline on the erythrocyte membrane.
    Sato Y; Miura T; Suzuki Y
    Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):555-8. PubMed ID: 2337973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Morphology and deformability of erythrocytes in muscular dystrophy].
    Garceau C; Leblond PF; Lyonnais J; Beaupré A
    Nouv Rev Fr Hematol (1978); 1978; 20(4):585-98. PubMed ID: 377225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of pentoxifylline on red blood cell deformability and blood viscosity under hyperosmolar conditions.
    Leonhardt H; Grigoleit HG
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Sep; 299(2):197-200. PubMed ID: 909613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chemiluminescence of blood plasma and functional status of the erythrocytes of patients with various hereditary neuromuscular diseases].
    Sitnikov VF; Khrennikov VIu; Teselkin IuO
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(3):376-81. PubMed ID: 3577527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of pentoxifylline on single red cell deformability.
    Seiffge D; Kiesewetter H
    Klin Wochenschr; 1981 Nov; 59(22):1271-2. PubMed ID: 7311396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correction by pentoxifylline of the abnormal fluorescence polarization of erythrocyte membranes from diabetic patients.
    Rahmani-Jourdheuil D; Juhan-Vague I; Roul C; Mourayre Y; Mishal Z; le Petit J; Vague P
    Eur J Clin Pharmacol; 1987; 31(6):725-8. PubMed ID: 3556379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new method of measuring red cell deformability and the effects of pentoxifylline.
    Isogai Y; Mochizuki K; Ashikaga M
    Curr Med Res Opin; 1981; 7(6):352-8. PubMed ID: 7238085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pentoxifylline and arterial hypertension in diabetes mellitus: long-term results in randomized groups].
    Solerte SB; Adamo S; Viola C; Zambianchi E; Ferrari E
    Ric Clin Lab; 1985; 15 Suppl 1():515-26. PubMed ID: 4035232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the vasoocclusive crisis of sickle cell disease IV. Mechanism of action of pentoxifylline (Trental).
    Ambrus JL; Meky N; Stadler S; Sills RH; Gastpar H; Raposa T
    J Med; 1988; 19(2):67-88. PubMed ID: 3171402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effectiveness of treatment during osteoarticular pain crises in drepanocytosis; based on the example of pentoxifylline].
    Pichard E; Duflo B; Coulibaly S; Mariko B; Monsempes JL; Traore HA; Diallo AD
    Bull Soc Pathol Exot Filiales; 1987; 80(5):834-40. PubMed ID: 3450443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of chronic oral pentoxifylline administration on murine erythrocyte deformability.
    Johnson FE; Tolman KC; Farr SA; Mawad MR; Raju PI; Hueneberg LR; Sutera SP
    J Surg Res; 1996 Jul; 63(2):387-92. PubMed ID: 8661231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.